Skip to main content
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1995 Oct;115(2):309–314. doi: 10.1017/s095026880005843x

Priorities in global measles control: report of an outbreak in N'Djamena, Chad.

A Ndikuyeze 1, A Cook 1, F T Cutts 1, S Bennett 1
PMCID: PMC2271404  PMID: 7589270

Abstract

In N'Djamena, capital of Chad, measles vaccination coverage of 12-23-month-old children fell from 61% in 1990 to 15% in 1993. A community survey of measles after an outbreak in 1993 showed that among children < 5 years of age, the mean monthly attack rate was 37 per 1,000 (95% CI, 32-43) and the mean case fatality rate was 7.4%. Measles incidence was highest (77/1,000/month) in children aged 9-11 months and fell among children > 3 years of age. Incidence rates were high (56/1,000/month) among 6-8-month-old children, but only 3 deaths occurred in this age group. Measles vaccine efficacy, estimated by comparing attack rates in unvaccinated and vaccinated children, was 71% (95% CI, 59-80%). Extrapolation of the results to the city population indicated that an estimated 19,000 cases and > 1,000 measles-associated deaths occurred in 1993. This preventable morbidity and mortality, in a city where coverage was formerly among the highest in Africa, shows the need for sustained global commitment to preventive health care.

Full text

PDF
309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Katz S. L., Gellin B. G. Measles vaccine: do we need new vaccines or new programs? Science. 1994 Sep 2;265(5177):1391–1392. doi: 10.1126/science.8073281. [DOI] [PubMed] [Google Scholar]
  2. Malfait P., Jataou I. M., Jollet M. C., Margot A., De Benoist A. C., Moren A. Measles epidemic in the urban community of Niamey: transmission patterns, vaccine efficacy and immunization strategies, Niger, 1990 to 1991. Pediatr Infect Dis J. 1994 Jan;13(1):38–45. doi: 10.1097/00006454-199401000-00009. [DOI] [PubMed] [Google Scholar]
  3. Miller E. The new measles campaign. BMJ. 1994 Oct 29;309(6962):1102–1103. doi: 10.1136/bmj.309.6962.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Orenstein W. A., Bernier R. H., Hinman A. R. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev. 1988;10:212–241. doi: 10.1093/oxfordjournals.epirev.a036023. [DOI] [PubMed] [Google Scholar]
  5. Peltola H., Heinonen O. P., Valle M., Paunio M., Virtanen M., Karanko V., Cantell K. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med. 1994 Nov 24;331(21):1397–1402. doi: 10.1056/NEJM199411243312101. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES